CoChat

Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy

Open access
Viswanathan, Shilpa, Justice, Amy C., Alexander, G. Caleb, Brown, Todd T., Gandhi, Neel R., McNicholl, Ian R., Rimland, David, Rodriguez-Barradas, Maria C., Jacobson, Lisa P. · 2015 · JAIDS Journal of Acquired Immune Deficiency Syndromes

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

BACKGROUND: We examined trends in adherence to highly active antiretroviral therapy (HAART) and HIV RNA suppression and estimated the minimum cutoff of adherence to newer HAART formulations needed for HIV RNA suppression by regimen type. METHODS: We used Veterans Affairs pharmacy dispensing data from the Veterans Aging Cohort Study Virtual Cohort between October 2000 and September 2010 and defined adherence as the duration of time the patient had the medications available, relative to the total number of days between refills for all antiretrovirals in a year. Temporal trends in adherence and viral load suppression were examined by the patient's most frequently used HAART regimen in the year. The minimum needed adherence was defined as the level at which the odds of suppression was not significantly different than that observed with ≥ 95% adherence using repeated-measures logistic regression. RESULTS: A total of 21,865 HAART users contributed 82,217 person-years of follow-up. There was a significant increase (P(trend) < 0.001) in the proportion virally suppressed even among those with <95% adherence (2001: 38% to 2010: 84%), and the trend was similar when restricting to their first HAART regimen. For nonnucleoside reverse transcriptase inhibitor multi-pill users, the odds of suppression did not differ for 85%-89% adherence compared to those with ≥ 95% adherence [odds ratios: 0.82 (0.64-1.04)], but for protease inhibitor users, the odds of suppression significantly differed if adherence levels were <95% compared to ≥ 95% adherence. CONCLUSIONS: Although all HIV-infected persons should be instructed to achieve perfect adherence, concerns of slightly lower adherence should not hinder prescribing new HAART regimens early in HIV infection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/qai.0000000000000643

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Cited by

See all 98

Metadata

Authors
Viswanathan, S., Justice, A. C., Alexander, G. C., Brown, T. T., Gandhi, N. R., McNicholl, I. R., Rimland, D., Rodriguez-Barradas, M. C., & Jacobson, L. P.
Affiliations
  • Michael E. DeBakey VA Medical Center (US)
  • Yale University (US)
  • Johns Hopkins University (US)
  • Emory University (US)
Corresponding author
  • Viswanathan, Shilpa
  • Alexander, G. Caleb
  • Brown, Todd T.
  • McNicholl, Ian R.
  • Jacobson, Lisa P.
Venue
JAIDS Journal of Acquired Immune Deficiency Syndromes
Published
2015-08-01
Volume
69
Issue
4
Pages
493-498
ISSN
1525-4135 (ISSN-L)
OpenAlex
W2323571515
Cited by
98
References
23
Citations by year
2026: 1 · 2025: 6 · 2024: 8 · 2023: 7 · 2022: 9 · 2021: 8 · 2020: 11 · 2019: 10 · 2018: 10 · 2017: 15 · 2016: 10 · 2015: 3
FWCI
9.80
Type
journal article
Language
en
Open access
Locations
  • JAIDS Journal of Acquired Immune Deficiency Syndromes (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (5u01aa020799-09, 4u24aa022007-05)
  • Agency for Healthcare Research and Quality (R01HS018372)
  • U.S. Public Health Service (U01-A1069918)
  • National Institute on Alcohol Abuse and Alcoholism (U24-AA022007, U01-AA020799, U01AA020790, U01AA020795, U24AA022001, U10AA013566, U24AA020794)
  • National Heart, Lung, and Blood Institute (R01HL095136, R01HL107345, R01HL090342)
  • National Institute of Mental Health (P30MH062294)
  • National Institute on Drug Abuse (R01DA035616)
  • National Cancer Institute (R01CA173754)
  • National Institute of Allergy and Infectious Diseases (UM1AI035043, K24AI114444, K24AI120834, P30AI050409)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
Keywords
medication adherence, HIV RNA suppression, highly active antiretroviral therapy, viral suppression, non-nucleoside reverse transcriptase inhibitors, protease inhibitors, antiretroviral regimens
MeSH terms
Adult, Female, Humans, Male, Middle Aged, RNA, Viral, Sensitivity and Specificity, HIV Infections, Anti-HIV Agents, Antiretroviral Therapy, Highly Active, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy. https://app.cochat.ai/papers/10.1097/qai.0000000000000643
The paper
Viswanathan, S., Justice, A. C., Alexander, G. C., Brown, T. T., Gandhi, N. R., McNicholl, I. R., Rimland, D., Rodriguez-Barradas, M. C., & Jacobson, L. P. (2015). Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. https://doi.org/10.1097/qai.0000000000000643

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.